Investors Asset Management Of Georgia Inc Gilead Sciences, Inc. Transaction History

Investors Asset Management Of Georgia Inc

$208 Million
Q1 2024

A detailed history of Investors Asset Management Of Georgia Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 19,131 shares of GILD stock, worth $1.27 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

19,131

Previous 18,847 1.51%

Holding current value

$1.27 Million

Previous $1.53 Million 8.19%

% of portfolio

0.67%

Previous 0.78%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$71.58 - $87.29 $20,328 - $24,790	284 Added 1.51%	19,131 $1.4 Million
Q4 2023 Jan 31, 2024	SELL	$73.27 - $83.09 $2,124 - $2,409	-29 Reduced 0.15%	18,847 $1.53 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $59,225 - $64,616	-801 Reduced 4.07%	18,876 $1.41 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $76 - $86	1 Added 0.01%	19,677 $1.52 Million
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $19,327 - $22,020	-250 Reduced 1.25%	19,676 $1.63 Million

Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $150,695 - $172,133	2,531 Added 14.55%	19,926 $1.23 Million
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $147,532 - $166,165	-2,556 Reduced 12.81%	17,395 $1.08 Million
Q1 2022 Apr 20, 2022	SELL	$57.92 - $72.58 $29,886 - $37,451	-516 Reduced 2.52%	19,951 $1.19 Million
Q4 2021 Feb 03, 2022	SELL	$64.88 - $73.64 $195,613 - $222,024	-3,015 Reduced 12.84%	20,467 $1.49 Million
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $279,221 - $301,248	4,125 Added 21.31%	23,482 $1.64 Million
Q2 2021 Jul 09, 2021	BUY	$63.47 - $69.35 $25,388 - $27,739	400 Added 2.11%	19,357 $1.33 Million
Q1 2021 Apr 21, 2021	BUY	$60.0 - $68.46 $3,000 - $3,422	50 Added 0.26%	18,957 $1.23 Million
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $20,677 - $23,560	-365 Reduced 1.89%	18,907 $1.1 Million
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $53,406 - $67,148	860 Added 4.67%	19,272 $1.22 Million
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $15,191 - $17,640	-210 Reduced 1.13%	18,412 $1.42 Million
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $385,487 - $493,754	6,155 Added 49.37%	18,622 $1.39 Million
Q4 2019 Jan 15, 2020	SELL	$61.62 - $67.78 $27,729 - $30,501	-450 Reduced 3.48%	12,467 $810,000
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $1,562 - $1,725	-25 Reduced 0.19%	12,917 $819,000
Q2 2019 Jul 10, 2019	BUY	$61.87 - $69.38 $18,561 - $20,814	300 Added 2.37%	12,942 $874,000
Q1 2019 Apr 17, 2019	BUY	$62.53 - $70.05 $35,329 - $39,578	565 Added 4.68%	12,642 $822,000
Q2 2018 Jul 27, 2018	BUY	$64.88 - $75.68 $5,190 - $6,054	80 Added 0.67%	12,077 $856,000
Q1 2018 Apr 11, 2018	BUY	$72.84 - $88.8 $72,840 - $88,800	1,000 Added 9.09%	11,997 $904,000
Q4 2017 Jan 11, 2018	BUY	$71.15 - $83.52 $8,538 - $10,022	120 Added 1.1%	10,997 $788,000
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $784,340 - $929,657	10,877	10,877 $881,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Asset Management Of Georgia Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investors Asset Management Of Georgia Inc with notifications on news.

Account

Investors Asset Management Of Georgia Inc Gilead Sciences, Inc. Transaction History